Skip to the main content
The Crier

high-throughput sequencing services

Cell Therapy Catapult LimitedNorth Eastservicesbelow threshold
Your saved contracts

What the buyer wrote

The primary aim of this procurement is to secure a high-throughput sequencing service provider to perform sequencing services for the Cell and Gene Therapy (CGT) Catapult on a fee-per-service basis. This service will support the CGT Catapult's mission of accelerating the commercialization of innovation from research and overcoming technical barriers in advanced therapy medicinal product (ATMP) development. The selected provider's services will complement CGT Catapult's unique technical facilities and expertise at its London site. This procurement seeks comprehensive high-throughput sequencing services. These services will be utilized for deep process characterization, particularly for proces…

Read all of it on Find a Tender →

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Genewiz UK Ltdends (5 Jan 2027)
Genewiz UK Ltdends (5 Jan 2027)
Genewiz UK Ltdends (6 Jan 2027)
Edinburgh Genetics Limitedends (6 Jan 2027)
Biomarker Technologies (BMK) GmbHends (5 Jan 2027)
Novogene (UK) Company Limitedends (6 Jan 2027)

Details

What the buyer calls it
high-throughput sequencing services
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
services
Lots
6
Work starts
6 Jan 2026
Work ends
5 Jan 2027
Where
in the North East, in the North West, in Yorkshire and The Humber, in the East Midlands, in the West Midlands, in the East of England, in London, in the South East, in the South West

Who the buyer named

Michael Strubel was the named contact on this notice. Questions closed on 4 Sep 2025, 17:00 BST.

michael.strubel@ct.catapult.org.uk